Target PharmaSolutions & Novartis to launch real-world dermatology study
Target PharmaSolutions has named Novartis as its first TARGET-DERM registry industry partner.
Read More
Tag: TARGET-DERM
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
